Research Reports Archives - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Research Reports

Drug Discovery
Research & Development
Tumor Markers

January 28, 2021

Existing drug offers targeted treatment for aggressive breast cancer

A new study claims palbociclib, an approved breast cancer drug, can treat an aggressive form of the cancer, bringing hope to thousands of afflicted women in the UK.

Continue

Existing drug offers targeted treatment for aggressive breast cancer

December 3, 2010

European conference participants agree to improve neurological diseases research

News
Research Reports

Drug Discovery

Research & Development

Ring Therapeutics signs partnerships to advance R&D in biomedical sciences

insitro collaborates with Lilly on metabolic disease treatments

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Neuvivo files NDA seeking FDA approval for ALS treatment

FDA grants priority review for AstraZeneca’s Calquence sNDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer

PCI Pharma announces bottling line expansion at Rockford site

Suppliers

No data found

Existing drug offers targeted treatment for aggressive breast cancer

European conference participants agree to improve neurological diseases research